Cytomegalovirus infection causes an increase of arterial blood pressure
- PMID: 19436702
- PMCID: PMC2673691
- DOI: 10.1371/journal.ppat.1000427
Cytomegalovirus infection causes an increase of arterial blood pressure
Abstract
Cytomegalovirus (CMV) infection is a common infection in adults (seropositive 60-99% globally), and is associated with cardiovascular diseases, in line with risk factors such as hypertension and atherosclerosis. Several viral infections are linked to hypertension, including human herpes virus 8 (HHV-8) and HIV-1. The mechanisms of how viral infection contributes to hypertension or increased blood pressure are not defined. In this report, the role of CMV infection as a cause of increased blood pressure and in forming aortic atherosclerotic plaques is examined. Using in vivo mouse model and in vitro molecular biology analyses, we find that CMV infection alone caused a significant increase in arterial blood pressure (ABp) (p<0.01 approximately 0.05), measured by microtip catheter technique. This increase in blood pressure by mouse CMV (MCMV) was independent of atherosclerotic plaque formation in the aorta, defined by histological analyses. MCMV DNA was detected in blood vessel samples of viral infected mice but not in the control mice by nested PCR assay. MCMV significantly increased expression of pro-inflammatory cytokines IL-6, TNF-alpha, and MCP-1 in mouse serum by enzyme-linked immunosorbent assay (ELISA). Using quantitative real time reverse transcriptase PCR (Q-RT-PCR) and Western blot, we find that CMV stimulated expression of renin in mouse and human cells in an infectious dose-dependent manner. Co-staining and immunofluorescent microscopy analyses showed that MCMV infection stimulated renin expression at a single cell level. Further examination of angiotensin-II (Ang II) in mouse serum and arterial tissues with ELISA showed an increased expression of Ang II by MCMV infection. Consistent with the findings of the mouse trial, human CMV (HCMV) infection of blood vessel endothelial cells (EC) induced renin expression in a non-lytic infection manner. Viral replication kinetics and plaque formation assay showed that an active, CMV persistent infection in EC and expression of viral genes might underpin the molecular mechanism. These results show that CMV infection is a risk factor for increased arterial blood pressure, and is a co-factor in aortic atherosclerosis. Viral persistent infection of EC may underlie the mechanism. Control of CMV infection can be developed to restrict hypertension and atherosclerosis in the cardiovascular system.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis.J Cardiovasc Transl Res. 2013 Feb;6(1):54-64. doi: 10.1007/s12265-012-9428-x. Epub 2012 Nov 29. J Cardiovasc Transl Res. 2013. PMID: 23192592 Free PMC article.
-
[Distribution of cytomegalovirus DNA in vascular tissues and the relationship between virus and atherosclersogenesis].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Oct;23(5):321-4. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009. PMID: 20387474 Chinese.
-
Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.Transfusion. 2006 Jun;46(6):889-95. doi: 10.1111/j.1537-2995.2006.00820.x. Transfusion. 2006. PMID: 16734804
-
Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models.Rev Med Virol. 2005 Sep-Oct;15(5):327-45. doi: 10.1002/rmv.475. Rev Med Virol. 2005. PMID: 16100703 Review.
-
Developmental disorders of the mouse brain induced by murine cytomegalovirus: animal models for congenital cytomegalovirus infection.Pathol Int. 1995 Feb;45(2):91-102. doi: 10.1111/j.1440-1827.1995.tb03428.x. Pathol Int. 1995. PMID: 7742931 Review.
Cited by
-
Posttransplant complications: molecular mechanisms and therapeutic interventions.MedComm (2020). 2024 Sep 2;5(9):e669. doi: 10.1002/mco2.669. eCollection 2024 Sep. MedComm (2020). 2024. PMID: 39224537 Free PMC article. Review.
-
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.Geroscience. 2024 Aug 29. doi: 10.1007/s11357-024-01323-9. Online ahead of print. Geroscience. 2024. PMID: 39207648
-
Association between cytomegalovirus infection and dyslipidemia in US: an NHANES analysis.Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):1883-1897. doi: 10.1007/s10096-024-04905-9. Epub 2024 Jul 27. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39066967
-
Trajectories of functional and structural myocardial parameters in post-COVID-19 syndrome-insights from mid-term follow-up by cardiovascular magnetic resonance.Front Cardiovasc Med. 2024 Apr 2;11:1357349. doi: 10.3389/fcvm.2024.1357349. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38628318 Free PMC article.
-
Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease.Int J Mol Sci. 2024 Jan 6;25(2):753. doi: 10.3390/ijms25020753. Int J Mol Sci. 2024. PMID: 38255826 Free PMC article. Review.
References
-
- Pass RF. Cytomegalovirus. In: Knipe DM, Howley PM, editors. Fields Virology. New York: Lippincott Williams & Wilkins. Vol. 2; 2001. pp. 2675–730.
-
- Peterslund NA. Herpesvirus infection: an overview of the clinical manifestations. Scand J Infect Dis (Suppl) 1991;80:15–20. - PubMed
-
- Takei H, Strong JP, Yutani C, Malcom GT. Comparison of coronary and aortic atherosclerosis in youth from Japan and the USA. Atherosclerosis. 2005;180:171–179. - PubMed
-
- Nascimento MM, Pecoits-Filho R, Lindholm B, Riella MC, Stenvinkel P. Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective. Blood Purif. 2002;20:454–458. - PubMed
-
- Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med. 2003;349:1113–1122. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
